Development theory, 538–544Diabetes mellitus, antipsychotic-related, 499–500Depersonalization disorder, 192Depression. Dibenzepines, 481–487Denial (ego defense), 545tDependent personality disorder, 277Developmental model, in adjustment disorder, 237Depressive disorders, 125–126. Development, impairment of, in adjustment disorder, 237DetoxifiDesensitization, for anxiety disorders, 168^652 in grief response, 392in HIV disease, 331Internet references, 144movie(s) involving, 144in premenstrual dysphoric disorder, 326sedative-hypnotic effects on, 519adverse reactions and side effects of, 484vs.action of, 482examples of, 481t–482tcontraindications and precautions for, 483benzodiazepine effects on, 410, 415chronic, in borderline personality disorder, 281substance-induced, 126, 146^ grief response, 399, 402t●^ cation. SUBJECT INDEXSee alsoSee Withdrawal, substance Major depressive disorderSee also Major depressive disorder
2506_Subject Index_639-682.indd 652 2506 Subject Index 639 Disruptive behavior disorders, 26–42Displacement (ego defense), 545tDibenzo-oxepino pyrrole, 492–493Diet. Dihydroindolones, 480–481Disorganized schizophrenia, 105Discontinuation syndrome, antidepressant-related, 441- 68 interactions of, 485action of, 480adverse reactions and side effects of, 481contraindications and precautions for, 480attention-defiexamples of, 480tconduct disorder, 27–29nursing diagnoses and interventions forroute and dosage for, 486–487interactions of, 481route and dosage for, 481 2 .indefensive coping, 32–34anxiety, 39–40impaired social interaction, 34–35dSeed 6 Nutrition 52 cit/hyperactivity disorder, 26–27 1 10/1/10 9:41:58 AM 0 / 1 / 10 9 : 41 : 58 AM
barré
(Barré)
#1